Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women? Combined analysis from two
by J Bonneterre 2024 Cited by 1135Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group
Researchers presented 12-year results for tamoxifen versus anastrozole [Arimidex], which demonstrated no significant difference in terms of disease recurrence.
was observed for recurrence-free survival in favour of ARIMIDEX versus tamoxifen. Again, the combination of ARIMIDEX and tamoxifen did not demonstrate any
In advanced breast cancer trials, the most common side effects seen with ARIMIDEX versus tamoxifen include hot flashes, nausea, decreased energy and
Bonneterre, J, Thurlimann, B, Robertson, JFR, et al. Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex
Arimidex vs. tamoxifen You may wonder how Arimidex compares with other medications that are prescribed for similar uses. Here we look at how Arimidex and tamoxifen are alike and different.
by S Sawada 2024 Cited by 37Anastro- zole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the tamoxifen or Arimidex randomized
Arimidex vs. tamoxifen You may wonder how Arimidex compares with other medications that are prescribed for similar uses. Here we look at how Arimidex and tamoxifen are alike and different.
Ziegler sisters
Scout Taylor Compton versus Danielle Harris
Danielle bregoli versus woah Vicky